Under Panacea Biotec’s restructuring programme, the company has appointed Susheel Umesh as Chief Executive of Domestic Formulations. Dr. Rajeeva Kumar Mangalum and Dinesh Singla have been appointed as Chief Operating Officer for Pharmaceutical Operations and Senior Vice President – Pharma Research & Pharma Regulatory Affairs respectively.
New Delhi – Panacea Biotec, one of India’s leading pharmaceutical and biotechnology company, as part of its organisational restructuring programme has announced key managerial appointments in its top-level leadership. Highly experienced internal and external professionals have been identified to lead different functions across Sales, Operations and R&D to drive sustainable growth.
Dr. Rajesh Jain, Managing Director, said, “We are pleased to announce the appointment of Susheel Umesh as Chief Executive - Domestic Formulations.” Susheel brings in 27 years of experience, deep understanding of the pharmaceutical industry and has managed P&Ls at Sanofi and Abbott. He has led multiple roles spanning from managing global brands to running a large commercial operation to create value and establish differentiation in the branded generic space. He has managed large teams and enjoys building and transforming teams to deliver great results through innovative practices. His in-depth understanding and experience of the pharmaceutical industry will ensure that the company continues to strengthen its position in the Indian pharmaceutical market.
Ankesh Jain, Director - Sales & Marketing who was directly looking after the domestic formulations business earlier will now focus on growing the firm’s formulations business internationally, with special focus on emerging markets, besides development and launch of new products in existing export markets. Under Ankesh’s leadership, the business built a solid foundation of brands in Organ transplant, Diabetic, Gastro, Oncology portfolio. All brands in these segments are among the top 3 brands in their category. Ankesh will work closely with Susheel over the next few months to ensure smooth transition.
Dr. Rajesh Jain also announced the elevation of:
Dr. Rajeeva Kumar Mangalum as Chief Operating Officer for Pharmaceutical Operations – Dr. Rajeeva brings in 35 years of Pharmaceutical Manufacturing experience out of which he has spent 25 years in Panacea Biotec. He has led and managed large teams and believes in achieving business objectives through team work, added Jain.
Dinesh Singla as Senior Vice President – Pharma Research & Pharma Regulatory Affairs – Dinesh brings in 24 years of Pharmaceutical Research experience out of which he has spent 12 years in Panacea Biotec. Previously, he has led teams to deliver innovation-based products both for domestic and international markets.